share_log

8-K: Current report

SEC ·  Sep 17, 2024 04:42

Summary by Moomoo AI

On September 10, 2024, AgriFORCE Growing Systems Ltd. (AgriFORCE) entered into an Equity Distribution Agreement with Maxim Group LLC (Maxim), allowing for the sale of common stock up to an aggregate offering price of $3,080,000. This agreement replaces a previous arrangement with B. Riley, Inc. The sales agreement enables AgriFORCE to offer and sell its shares through Maxim, acting as a sales agent or principal, with the potential to reach the maximum offering price through time-to-time transactions. The agreement stipulates that Maxim will make reasonable efforts to sell the shares at market prices and will receive a commission for its services. The common shares involved in the transaction are registered on The Nasdaq Capital Market under the symbol AGRI. AgriFORCE, an...Show More
On September 10, 2024, AgriFORCE Growing Systems Ltd. (AgriFORCE) entered into an Equity Distribution Agreement with Maxim Group LLC (Maxim), allowing for the sale of common stock up to an aggregate offering price of $3,080,000. This agreement replaces a previous arrangement with B. Riley, Inc. The sales agreement enables AgriFORCE to offer and sell its shares through Maxim, acting as a sales agent or principal, with the potential to reach the maximum offering price through time-to-time transactions. The agreement stipulates that Maxim will make reasonable efforts to sell the shares at market prices and will receive a commission for its services. The common shares involved in the transaction are registered on The Nasdaq Capital Market under the symbol AGRI. AgriFORCE, an emerging growth company, has filed the necessary documentation with the U.S. Securities and Exchange Commission (SEC), including a prospectus supplement and accompanying prospectus. The company has also affirmed its compliance with the Securities Act of 1933 and the Securities Exchange Act of 1934, ensuring that no material misstatements or omissions are present in the filings. The agreement is subject to standard regulatory and company approvals, and the shares will be offered in accordance with the SEC's regulations.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more